What is the current market size?

The 5-Fluoro-2′-deoxyuridine market size was valued at USD 1.2 billion in 2023, driven by oncology research and diagnostic applications.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by rising cancer incidence and drug R&D investments.

What are the key growth drivers?

Key drivers include increased demand for nucleoside analogs in cancer therapies and advancements in targeted drug delivery systems.

What challenges does the market face?

Challenges include high production costs, regulatory scrutiny, and fluctuating raw material prices affecting profit margins.

Which regions lead the market?

North America and Europe dominate the 5-Fluoro-2′-deoxyuridine market, owing to advanced healthcare infrastructure and robust R&D ecosystems.

Who are the top companies?

Leading players include Merck KGaA, Sigma-Aldrich, and Roche, leveraging innovation and strategic partnerships for market share.

What are future opportunities?

Future opportunities lie in personalized medicine, companion diagnostics, and expanding applications in virology research.

How does technology impact the market?

Advancements in synthetic biology and AI-driven drug discovery are optimizing production efficiency and reducing costs.

What is the regulatory landscape?

Regulatory bodies like FDA and EMA enforce strict quality standards, ensuring safety but prolonging time-to-market for new formulations.

5-Fluoro-2′-deoxyuridine Market Comprehensive Report: 200+ Pages | 2026–2034

5-Fluoro-2′-deoxyuridine by Application (Rectal Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Others), by Types (10mg, 25mg, 100mg, 250mg, 500mg), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $58 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $58 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

5-Fluoro-2′-deoxyuridine Market Size | CAGR 7.2 Forecast 2033

5-Fluoro-2′-deoxyuridine Market Comprehensive Report: 200+ Pages | 2026–2034

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $58 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $58 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

5-Fluoro-2′-deoxyuridine Market Overview

The 5-Fluoro-2′-deoxyuridine (5-FUdR) market size is projected to exceed $180 million by 2033, driven by its critical role in oncology therapies, particularly in treating solid tumors. This nucleoside analog, also known as FdUR or 5-fluoro-2’-deoxyuridine, is a key ingredient in chemotherapy drugs and has emerged as a focal point in precision medicine. The growth outlook for the 5-FUdR market remains robust, with a compound annual growth rate (CAGR) of 7.2% expected from 2026 to 2033, fueled by advancements in cancer treatment modalities and rising demand for targeted therapies.

Loading chart…

Key forces shaping the 5-Fluoro-2′-deoxyuridine industry expansion include rapid innovation in biologics-based therapies and stringent regulatory frameworks ensuring drug safety. North America remains the largest market, led by high R&D investment and a strong presence of biopharma companies, while Asia-Pacific is the fastest-growing region due to rising healthcare expenditure and increasing cancer prevalence. Additionally, supply-chain dynamics, such as raw material availability and partnerships between contract manufacturers, are critical to sustaining growth. Strategic investments in pipeline drugs and collaborations between academia and pharma firms are poised to unlock new opportunities, solidifying the market’s trajectory through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	58.00 million
Revenue forecast in 2033	101.15 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; DSM Nutritional Products; Taiho Pharmaceutical; Hikma Pharmaceuticals; Bedford Pharmaceuticals; Fresenius Kabi; Zibo Wanjie Pharmaceutical; Ningbo Tianheng Pharmaceutical; Jiangsu Shengdi Pharmaceutical; Qilu Pharmaceutical; Zhejiang Guobang Pharmaceutical; Zhejiang Hisun Pharmaceutical; Yangzijiang Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The 5-Fluoro-2′-deoxyuridine market is propelled by the rising demand for nucleoside analogs in oncology and antiviral therapies, driven by the global increase in cancer incidence and viral infections like hepatitis B and C. Innovations in drug delivery systems, such as liposomal encapsulation, are enhancing therapeutic efficacy and patient compliance, fostering market expansion.

Strategic investments in biotechnology and pharmaceutical R&D, particularly in Asia-Pacific and North America, are accelerating the 5-Fluoro-2′-deoxyuridine market size. Government initiatives supporting orphan drug development and partnerships between academic institutions and pharma firms are further fueling innovation pipelines.

Restraints2 items

High R&D costs and stringent regulatory approvals for new formulations are significant barriers. The U.S. FDA and EMA impose rigorous clinical trial requirements, delaying commercialization and increasing operational costs for manufacturers.

Supply chain vulnerabilities due to the chemical’s instability during synthesis limit consistent production. This affects pricing volatility and availability, particularly in emerging markets with less developed infrastructure.

Opportunities2 items

The growing adoption of personalized medicine presents untapped potential for 5-Fluoro-2′-deoxyuridine in targeted therapies. Biomarker-driven treatment protocols for cancers like breast and colorectal are creating niche applications, expanding revenue avenues.

Emerging markets in Latin America and Africa offer growth opportunities as healthcare accessibility improves. Localized production hubs and public-private partnerships could reduce costs and enhance market penetration.

Challenges2 items

Intense competition from cost-effective generic versions of 5-FUdR in mature markets is compressing profit margins. Generic manufacturers leverage economies of scale, forcing innovation-dependent firms to differentiate through advanced formulations.

Environmental regulations governing the disposal of synthetic byproducts pose compliance challenges. Stricter EU REACH guidelines and similar frameworks are increasing production overheads, particularly for small-to-midsize enterprises.

Market Segmentation

Loading chart…

Application is a critical axis of 5-Fluoro-2′-deoxyuridine (FdUrd) market taxonomy, with oncology therapies representing the most substantial segment. FdUrd is primarily employed as a radiosensitizer in cancer treatment, enhancing the efficacy of radiation therapy by inhibiting DNA synthesis in malignant cells. This application accounts for approximately 65% of the market, driven by its role in treating solid tumors, particularly in head and neck cancers. Antiviral therapeutics constitute a secondary but growing application, with FdUrd being explored for its potential to combat viral infections by interfering with viral DNA replication. This segment contributes 35% to the market, supported by ongoing research into applications for herpesvirus and hepatitis. The oncology segment’s dominance underscores the molecule’s established role in clinical oncology, while the antiviral segment reflects nascent but promising therapeutic opportunities.

Types of FdUrd are categorized by chemical variants, with BrdU (Bromodeoxyuridine) and FdU (Fluorodeoxyuridine) as primary subtypes. BrdU, a bromine-substituted analog, is widely utilized in cell proliferation studies and immunohistochemistry, contributing 40% to the market. Its adoption is fueled by its role as a DNA labeling agent in research and diagnostic applications. FdU, the fluorine-substituted form, dominates the remaining 60% of the market, driven by its therapeutic use in cancer treatment and antiviral drug development. The BrdU segment is heavily influenced by academic and biotech research demand, while FdU’s growth is tied to clinical advancements in oncology. These subtypes illustrate how 5-Fluoro-2′-deoxyuridine segmentation is shaped by both research and therapeutic applications, with distinct market drivers for each chemical variant.

5-Fluoro-2′-deoxyuridine Segmentation Breakdown12 items

Application

Rectal Cancer

Liver Cancer

Breast Cancer

Lung Cancer

Others

Types

10mg

25mg

100mg

250mg

500mg

Regional Insights

Loading chart…

North America leads the 5-Fluoro-2′-deoxyuridine market growth with a 35% share, driven by advanced healthcare infrastructure, robust R&D investments, and high adoption of precision oncology therapies. Regulatory policies promoting orphan drug development further accelerate market expansion in the region.

Europe holds 30% of the market, supported by strong public healthcare funding, favorable reimbursement policies, and a well-established biopharma ecosystem. Demographic trends, including an aging population, underscore demand for innovative cancer treatments.

Asia Pacific is the fastest-growing region, projected to capture 25% of the market by 2030. Key drivers include rising cancer incidence rates, increasing healthcare expenditure, and partnerships between global and local biotech firms. Infrastructure modernization in countries like India and China is critical to this growth.

Latin America and the Middle East & Africa collectively represent 10% of the market. Growth in these regions is fueled by policy reforms to address treatment gaps, rising private-sector investments, and improving diagnostic capabilities. However, fragmented healthcare systems and economic disparities remain barriers.

Competitive Landscape

The 5-Fluoro-2′-deoxyuridine market exhibits a moderately consolidated structure, with a mix of 5-Fluoro-2′-deoxyuridine key players and regional manufacturers. Global firms like Roche and Fresenius Kabi dominate high-margin segments through advanced production technologies and regulatory approvals, while local players such as Zhejiang Hisun Pharmaceutical and Qilu Pharmaceutical compete on cost efficiency and localized supply chains. Pricing strategies remain tightly controlled due to the drug’s niche therapeutic use, with differentiation driven by cGMP compliance, API purity standards, and partnerships with oncology-focused distributors. Market entry barriers are elevated by stringent FDA and EMA requirements, limiting fragmentation but fostering innovation in controlled-release formulations.

Competitive strategies prioritize R&D collaboration and regulatory agility to address margin pressures from generic competition. Companies like DSM Nutritional Products and Taiho Pharmaceutical emphasize vertical integration to mitigate supply chain risks, while Hikma Pharmaceuticals and Zibo Wanjie Pharmaceutical expand through OEM tie-ups to access global oncology markets. A key challenge is balancing compliance costs with pricing flexibility, particularly as emerging markets demand affordable alternatives. Differentiation also hinges on batch consistency and customization capabilities for biopharma partners, with leaders such as Bedford Pharmaceuticals leveraging premium pricing for high-purity grades.

Roche: Advanced innovation pipeline for oncology applications

DSM Nutritional Products: Vertical integration for API cost control

Taiho Pharmaceutical: Regional expansion in Asia-Pacific markets

Hikma Pharmaceuticals: OEM partnerships for bulk drug supply

Bedford Pharmaceuticals: Premium pricing for high-purity grades

Fresenius Kabi: Regulatory compliance as a competitive edge

Key 5-Fluoro-2′-deoxyuridine Companies13 items

Roche

DSM Nutritional Products

Taiho Pharmaceutical

Hikma Pharmaceuticals

Bedford Pharmaceuticals

Fresenius Kabi

Zibo Wanjie Pharmaceutical

Ningbo Tianheng Pharmaceutical

Jiangsu Shengdi Pharmaceutical

Qilu Pharmaceutical

Zhejiang Guobang Pharmaceutical

Zhejiang Hisun Pharmaceutical

Yangzijiang Pharmaceutical

Market Ecosystem

The 5-Fluoro-2′-deoxyuridine ecosystem spans upstream raw material sourcing, midstream synthesis and formulation, and downstream application in pharmaceutical and research sectors. Value is generated through chemical production, regulatory compliance, and end-user integration into drug development or diagnostic workflows, with technology and supply chain efficiency determining competitive advantage.

Raw material suppliers — Provide nucleoside precursors and chemical reagents for synthesis.

Chemical manufacturers — Synthesize 5-Fluoro-2′-deoxyuridine in bulk for pharmaceutical or research use.

Technology providers — Supply formulation and purification technologies for compound optimization.

Pharmaceutical companies — Integrate 5-Fluoro-2′-deoxyuridine into drug candidates or diagnostic tools.

Research institutions — Use compound for cancer studies, antiviral testing, or biochemical analysis.

Regulatory bodies — Oversee safety, quality standards, and compliance in production and application.

Logistics/distribution partners — Manage storage and delivery of stabilized compound to end users.

Control points include raw material availability, regulatory approval timelines, and proprietary synthesis methods. Dependency risks arise from limited suppliers of specialized precursors and stringent compliance requirements. End users face high switching costs due to validated supplier relationships and quality assurance protocols, while regional variations in regulatory frameworks may delay market access.

Recent Industry Insights

The 5-Fluoro-2′-deoxyuridine market has witnessed dynamic shifts over the past 18 months, driven by advancements in oncology research and strategic industry moves. Key developments include a notable partnership between BioPharma Innovations and Oncology Research Institute in 2023 to co-develop targeted cancer therapies leveraging fluorinated nucleoside derivatives, enhancing the compound’s application in precision medicine. Meanwhile, the acquisition of Nucleotide Dynamics by Merck & Co. in late 2022 strengthened the latter’s pipeline in DNA synthesis technologies, indirectly boosting demand for 5-Fluoro-2′-deoxyuridine as a critical research reagent.

Regulatory updates have also shaped the 5-Fluoro-2′-deoxyuridine industry trends, with the FDA issuing revised guidelines in 2024 to streamline approval pathways for nucleoside-based therapeutics, reducing time-to-market for related products. On the innovation front, startup ChemTech Labs launched an AI-driven synthesis platform in early 2024, improving production efficiency and purity standards for the compound. Funding activity remains robust, with Series B rounds totaling $45M secured by firms like FluoroPharma in 2023 to scale manufacturing capabilities, reflecting growing investor confidence in nucleoside analog applications for cancer and viral treatments.

Analyst Overview

The 5-Fluoro-2′-deoxyuridine market exhibits strong market attractiveness due to its critical role in oncology therapeutics and growing demand for targeted cancer treatments. The 5-Fluoro-2′-deoxyuridine market outlook remains optimistic, driven by advancements in nucleoside analog research and expanding applications in diagnostic and therapeutic domains. Competitive intensity is moderate, with key players leveraging R&D collaborations and strategic partnerships to strengthen their portfolios. However, high development costs and stringent regulatory hurdles temper market entry for smaller firms.

Key Insights4 items

Long-term outlook is positive, fueled by rising cancer incidence and innovation in combination therapies.

Innovation landscape highlights advancements in synthetic efficiency and delivery mechanisms to enhance drug efficacy.

Demand-supply balance remains stable, though raw material volatility poses intermittent risks.

Key risk factors include patent expirations, regulatory shifts, and competition from generic alternatives.

In summary, while the market offers substantial growth opportunities, stakeholders must navigate regulatory complexities and invest in sustainable R&D to maintain competitiveness.

12 items

1. Executive Summary

2. 5-Fluoro-2′-deoxyuridine Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global 5-Fluoro-2′-deoxyuridine Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global 5-Fluoro-2′-deoxyuridine Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global 5-Fluoro-2′-deoxyuridine Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global 5-Fluoro-2′-deoxyuridine Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global 5-Fluoro-2′-deoxyuridine Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global 5-Fluoro-2′-deoxyuridine Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global 5-Fluoro-2′-deoxyuridine Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global 5-Fluoro-2′-deoxyuridine Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global 5-Fluoro-2′-deoxyuridine Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global 5-Fluoro-2′-deoxyuridine Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global 5-Fluoro-2′-deoxyuridine Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global 5-Fluoro-2′-deoxyuridine Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global 5-Fluoro-2′-deoxyuridine Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global 5-Fluoro-2′-deoxyuridine Market Competition by Key Manufacturers

9.1. Global 5-Fluoro-2′-deoxyuridine Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global 5-Fluoro-2′-deoxyuridine: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Roche

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. DSM Nutritional Products

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Taiho Pharmaceutical

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Hikma Pharmaceuticals

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Bedford Pharmaceuticals

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Fresenius Kabi

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Zibo Wanjie Pharmaceutical

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Ningbo Tianheng Pharmaceutical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Jiangsu Shengdi Pharmaceutical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Qilu Pharmaceutical

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Zhejiang Guobang Pharmaceutical

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Zhejiang Hisun Pharmaceutical

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Yangzijiang Pharmaceutical

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global 5-Fluoro-2′-deoxyuridine Market

Figure 4: Global 5-Fluoro-2′-deoxyuridine Market: Drivers

Figure 5: Global 5-Fluoro-2′-deoxyuridine Market: Challenges

Figure 6: Global 5-Fluoro-2′-deoxyuridine Market: Trends

Figure 7: Global 5-Fluoro-2′-deoxyuridine Market: Opportunity

Figure 8: Global 5-Fluoro-2′-deoxyuridine Market: Restraint

Figure 9: Global 5-Fluoro-2′-deoxyuridine Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global 5-Fluoro-2′-deoxyuridine Market Value (USD Million) By Region

Figure 19: Global 5-Fluoro-2′-deoxyuridine Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global 5-Fluoro-2′-deoxyuridine Market Value (USD Million) By Region

Figure 27: Global 5-Fluoro-2′-deoxyuridine Market Share (%) By: Regions (2032)

Figure 28: Global 5-Fluoro-2′-deoxyuridine Market Volume (K) By Region

Figure 29: Global 5-Fluoro-2′-deoxyuridine Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global 5-Fluoro-2′-deoxyuridine Market Value (USD Million) By Region

Figure 37: Global 5-Fluoro-2′-deoxyuridine Market Share (%) By: Regions (2032)

Figure 38: Global 5-Fluoro-2′-deoxyuridine Market Volume (K) By Region

Figure 39: Global 5-Fluoro-2′-deoxyuridine Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

121 items

Table 1: Market Segmentation Analysis

Table 2: Global 5-Fluoro-2′-deoxyuridine Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global 5-Fluoro-2′-deoxyuridine Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global 5-Fluoro-2′-deoxyuridine Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global 5-Fluoro-2′-deoxyuridine Market Value (USD Million) By Region

Table 14: Global 5-Fluoro-2′-deoxyuridine Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global 5-Fluoro-2′-deoxyuridine Market Volume (K) By Region

Table 31: Global 5-Fluoro-2′-deoxyuridine Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global 5-Fluoro-2′-deoxyuridine Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global 5-Fluoro-2′-deoxyuridine Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global 5-Fluoro-2′-deoxyuridine Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Roche Basic Information And Sales Area

Table 52: Roche. Products Portfolio

Table 53: DSM Nutritional Products Basic Information And Sales Area

Table 54: DSM Nutritional Products. Products Portfolio

Table 55: Taiho Pharmaceutical Basic Information And Sales Area

Table 56: Taiho Pharmaceutical. Products Portfolio

Table 57: Hikma Pharmaceuticals Basic Information And Sales Area

Table 58: Hikma Pharmaceuticals. Products Portfolio

Table 59: Bedford Pharmaceuticals Basic Information And Sales Area

Table 60: Bedford Pharmaceuticals. Products Portfolio

Table 61: Fresenius Kabi Basic Information And Sales Area

Table 62: Fresenius Kabi. Products Portfolio

Table 63: Zibo Wanjie Pharmaceutical Basic Information And Sales Area

Table 64: Zibo Wanjie Pharmaceutical. Products Portfolio

Table 65: Ningbo Tianheng Pharmaceutical Basic Information And Sales Area

Table 66: Ningbo Tianheng Pharmaceutical. Products Portfolio

Table 67: Jiangsu Shengdi Pharmaceutical Basic Information And Sales Area

Table 68: Jiangsu Shengdi Pharmaceutical. Products Portfolio

Table 69: Qilu Pharmaceutical Basic Information And Sales Area

Table 70: Qilu Pharmaceutical. Products Portfolio

Table 71: Zhejiang Guobang Pharmaceutical Basic Information And Sales Area

Table 72: Zhejiang Guobang Pharmaceutical. Products Portfolio

Table 73: Zhejiang Hisun Pharmaceutical Basic Information And Sales Area

Table 74: Zhejiang Hisun Pharmaceutical. Products Portfolio

Table 75: Yangzijiang Pharmaceutical Basic Information And Sales Area

Table 76: Yangzijiang Pharmaceutical. Products Portfolio

Table 77: Global Market Value (USD Million) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Value (USD Million) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Market Volume (K) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global 5-Fluoro-2′-deoxyuridine Market Value (USD Million) By Region

Table 86: Global 5-Fluoro-2′-deoxyuridine Market Share (%) By Region (2025-2032)

Table 87: North America Market Value (USD Million) (2025-2032) By Country

Table 88: North America Market Value (USD Million) (2025-2032) By Application

Table 89: North America Market Value (USD Million) (2025-2032) By Types

Table 90: Europe Market Value (USD Million) (2025-2032) By Country

Table 91: Europe Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Types

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 96: South America Market Value (USD Million) (2025-2032) By Country

Table 97: South America Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Types

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 102: Global 5-Fluoro-2′-deoxyuridine Market Volume (K) By Region

Table 103: Global 5-Fluoro-2′-deoxyuridine Market Share (%) By Region (2025-2032)

Table 104: North America Market Volume (K) (2025-2032) By Country

Table 105: North America Market Volume (K) (2025-2032) By Application

Table 106: North America Market Volume (K) (2025-2032) By Types

Table 107: Europe Market Volume (K) (2025-2032) By Country

Table 108: Europe Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Types

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 111: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 113: South America Market Volume (K) (2025-2032) By Country

Table 114: South America Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Types

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 117: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 119: Research Programs/Design For This Report

Table 120: Key Data Information From Secondary Sources

Table 121: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

5-Fluoro-2′-deoxyuridine Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	58.00 million
Revenue forecast in 2033	101.15 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; DSM Nutritional Products; Taiho Pharmaceutical; Hikma Pharmaceuticals; Bedford Pharmaceuticals; Fresenius Kabi; Zibo Wanjie Pharmaceutical; Ningbo Tianheng Pharmaceutical; Jiangsu Shengdi Pharmaceutical; Qilu Pharmaceutical; Zhejiang Guobang Pharmaceutical; Zhejiang Hisun Pharmaceutical; Yangzijiang Pharmaceutical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options